By Matt Wagner, CFA Associate, Research On November 9, 2020, Pfizer announced its highly effective COVID-19 vaccine would soon be submitted for FDA emergency-use approval. 2021 was being billed as the year of “the Great Reopening.” International markets like Japan, which skew more...